Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11689583rdf:typepubmed:Citationlld:pubmed
pubmed-article:11689583lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:11689583lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:11689583lifeskim:mentionsumls-concept:C0221912lld:lifeskim
pubmed-article:11689583lifeskim:mentionsumls-concept:C0027627lld:lifeskim
pubmed-article:11689583lifeskim:mentionsumls-concept:C0037633lld:lifeskim
pubmed-article:11689583lifeskim:mentionsumls-concept:C1519552lld:lifeskim
pubmed-article:11689583lifeskim:mentionsumls-concept:C1096776lld:lifeskim
pubmed-article:11689583lifeskim:mentionsumls-concept:C0206012lld:lifeskim
pubmed-article:11689583lifeskim:mentionsumls-concept:C1382100lld:lifeskim
pubmed-article:11689583lifeskim:mentionsumls-concept:C0068006lld:lifeskim
pubmed-article:11689583pubmed:issue21lld:pubmed
pubmed-article:11689583pubmed:dateCreated2001-11-5lld:pubmed
pubmed-article:11689583pubmed:abstractTextTo compare 6% miltefosine solution (Miltex; Asta Medica, Frankfurt, Germany), a new topical cytostatic drug, with placebo as palliative treatment for cutaneous metastases from breast cancer.lld:pubmed
pubmed-article:11689583pubmed:languageenglld:pubmed
pubmed-article:11689583pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11689583pubmed:citationSubsetIMlld:pubmed
pubmed-article:11689583pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11689583pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11689583pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11689583pubmed:statusMEDLINElld:pubmed
pubmed-article:11689583pubmed:monthNovlld:pubmed
pubmed-article:11689583pubmed:issn0732-183Xlld:pubmed
pubmed-article:11689583pubmed:authorpubmed-author:DavidMMlld:pubmed
pubmed-article:11689583pubmed:authorpubmed-author:HardyJJlld:pubmed
pubmed-article:11689583pubmed:authorpubmed-author:LeonardRRlld:pubmed
pubmed-article:11689583pubmed:authorpubmed-author:HoustonSSlld:pubmed
pubmed-article:11689583pubmed:authorpubmed-author:SimmondsPPlld:pubmed
pubmed-article:11689583pubmed:authorpubmed-author:MansiJJlld:pubmed
pubmed-article:11689583pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:11689583pubmed:issnTypePrintlld:pubmed
pubmed-article:11689583pubmed:day1lld:pubmed
pubmed-article:11689583pubmed:volume19lld:pubmed
pubmed-article:11689583pubmed:ownerNLMlld:pubmed
pubmed-article:11689583pubmed:authorsCompleteYlld:pubmed
pubmed-article:11689583pubmed:pagination4150-9lld:pubmed
pubmed-article:11689583pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11689583pubmed:meshHeadingpubmed-meshheading:11689583...lld:pubmed
pubmed-article:11689583pubmed:meshHeadingpubmed-meshheading:11689583...lld:pubmed
pubmed-article:11689583pubmed:meshHeadingpubmed-meshheading:11689583...lld:pubmed
pubmed-article:11689583pubmed:meshHeadingpubmed-meshheading:11689583...lld:pubmed
pubmed-article:11689583pubmed:meshHeadingpubmed-meshheading:11689583...lld:pubmed
pubmed-article:11689583pubmed:meshHeadingpubmed-meshheading:11689583...lld:pubmed
pubmed-article:11689583pubmed:meshHeadingpubmed-meshheading:11689583...lld:pubmed
pubmed-article:11689583pubmed:meshHeadingpubmed-meshheading:11689583...lld:pubmed
pubmed-article:11689583pubmed:meshHeadingpubmed-meshheading:11689583...lld:pubmed
pubmed-article:11689583pubmed:meshHeadingpubmed-meshheading:11689583...lld:pubmed
pubmed-article:11689583pubmed:meshHeadingpubmed-meshheading:11689583...lld:pubmed
pubmed-article:11689583pubmed:meshHeadingpubmed-meshheading:11689583...lld:pubmed
pubmed-article:11689583pubmed:meshHeadingpubmed-meshheading:11689583...lld:pubmed
pubmed-article:11689583pubmed:meshHeadingpubmed-meshheading:11689583...lld:pubmed
pubmed-article:11689583pubmed:meshHeadingpubmed-meshheading:11689583...lld:pubmed
pubmed-article:11689583pubmed:year2001lld:pubmed
pubmed-article:11689583pubmed:articleTitleRandomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer.lld:pubmed
pubmed-article:11689583pubmed:affiliationWestern General Hospital, Edinburgh, UK. r.c.f.leonard@swan.ac.uklld:pubmed
pubmed-article:11689583pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11689583pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:11689583pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:11689583pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:11689583pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:11689583pubmed:publicationTypeClinical Trial, Phase IIIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11689583lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11689583lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11689583lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11689583lld:pubmed